JENNIFER HUMPHREY: Open Payments
NPI 1639642986 · SAINT PETERS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,541 in 114 payments from 22 companies in 2025. Trend: 2023 $165 · 2024 $353 · 2025 $2,541
Food & beverage: $2,372Education: $169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $744 |
| Janssen Biotech, Inc. | 15 | $472 |
| PFIZER INC. | 10 | $174 |
| QOL Medical, LLC | 6 | $133 |
| Ardelyx, Inc. | 7 | $116 |
| Regeneron Healthcare Solutions, Inc. | 3 | $98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Phathom Pharmaceuticals, Inc. | 5 | $76 |
Products named: TREMFYA, RINVOQ, SKYRIZI, LINZESS, Sucraid, IBSRELA, XELJANZ, DUPIXENT.
Industry payments across MO — which companies pay providers there.
